Clinical trial
A Phase 2 Study to Determine the Effects of BXT-51072 in Diabetic Patients…
NCT00320502 · Synvista Therapeutics, Inc, Industry · Completed
Key facts
| NCT number | NCT00320502 |
|---|---|
| Title | A Phase 2 Study to Determine the Effects of BXT-51072 in Diabetic Patients Undergoing Angioplasty (PCI) |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Determine the Effects of BXT-51072 on CK-MB in High-Risk Type 2 Diabetic Patients Undergoing Elective Percutaneous Coronary Intervention |
| Lead sponsor | Synvista Therapeutics, Inc, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Coronary Syndrome, Type 2 Diabetes |
| Intervention type | Drug |
| Interventions | BXT-51072 |
| Enrollment | 60 |
| Start date | May 1, 2006 |
| Primary completion | Mar 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | May 3, 2006 |
| Last update posted | Aug 25, 2008 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: